Market News

Linius Technologies (ASX:LNU), a pioneer in cloud-based video solutions, is set to make a significant impact on the US college sports market with its latest venture. Linius has announced a groundbreaking agreement to provide its sports solution, Whizzard, to the Peach Belt Conference (PBC), marking its entry into the lucrative US collegiate sports market. Under […]

Chimeric Therapeutics (ASX:CHM), an Australian company specialising in cell therapy, has reported significant in vitro findings for its chlorotoxin (CLTX) chimeric antigen receptor (CAR) NK cell therapy, CHM 1301. These preclinical results highlight the therapy’s notable efficacy against ovarian and pancreatic cancers, suggesting potential advancements in cancer treatment. CHM 1301 represents a fusion of Chimeric’s

Sequoia Financial Group Limited (ASX:SEQ) Managing Director and CEO Garry Crole and Chairman John Larsen present at the company’s 2023 AGM. Chairman’s Speech Good morning, ladies, and gentlemen. My name is John Larsen, Chairman of Sequoia Financial Group Ltd and it is my pleasure to welcome you to our 2023 Annual General Meeting. I welcome

The S&P/ASX 200 is 0.52 per cent lower at 7,036.40. Aus. energy stocks are trading in the red due to the postponement of an OPEC meeting to later next week, dampening hopes of the cartel tightening its supplies.  The SPI futures are pointing to a fall of 37 points. Best and worst performers The best-performing

To register for Friday’s webinar click here. Chimeric Therapeutics (ASX:CHM) announced positive preclinical data for CHM 1301, the Company’s off-the-shelf cell therapy. The results show up to 300% enhanced cell killing demonstrated compared to first generation NK cells and there is evidence of expansion into two new solid tumours – pancreatic cancer and ovarian cancer.

Inflation data from the United States has reinforced the belief in a Goldilocks-style soft landing for the economy in the coming year. Despite this, there are compelling reasons to keep an eye on the precious metal as a viable investment option. While historically, gold has shone in times of economic turbulence, certain factors in 2024

Paul Sanger: I’m Paul Sanger for the Finance News Network. And today, I’m talking with WT Financial Group (ASX:WTL) and they have a market cap of 29 million. Over the past two years, WT Financial Group Limited has established itself amongst the very largest financial advisor networks in Australia. Its wealth management, retirement planning, and personal

Tower, the New Zealand-based insurer, will not pay a final dividend due to the substantial costs incurred from storms, floods, and cyclones in early 2023. On Thursday, the company disclosed a loss of NZ$1.2 million for the year, a significant decline from the NZ$18.9 million profit recorded the previous year. The company’s underlying result, which

Stocks rose Wednesday after yields briefly fell to their lowest level in two months, and the November market rally broadened into the Thanksgiving holiday. The Dow Jones Industrial Average gained about 184.74 points, or 0.53 per cent, to 35,273.03. The S&P 500 climbed 0.41 per cent to 4,556.62. The Nasdaq Composite advanced 0.46 per cent

In a recent development, Citi analysts have upgraded their short-term iron ore price forecast to a staggering US$140 per tonne, citing China’s anticipated fiscal stimulus measures. The upgraded outlook reflects growing expectations of a substantial and earlier-than-expected stimulus push from China’s government, propelling iron ore prices to levels not seen since June 2022. China’s dwindling